Navigation Links
Promus in Medical News

Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study

...da. Abbott also supplies a private-label version of XIENCE V to Boston Scientific called the PROMUS(R) Everolimus-Eluting Coronary Stent System. promus is designed and manufactured by Abbott and supplied to Boston Scientific as part of a distribution agreement between the two companies. Everolimu...

Boston Scientific Announces Schedule for EuroPCR 2009

...p.m. in Room 129. promus (R) Stent. Eberhard Grube, M.D., will present...c exhibit booth. TAXUS, Express, Express2 and promus are trademarks of Boston Scientific Corporation or its affiliates. The promus Stent is a private-labeled XIENCE V Everolimus-Elu...

Boston Scientific Announces Schedule For ACC 2009

... Sunday, March 29 promus (R) and TAXUS (R) Stents . During a poster ...ources. TAXUS, Express, Express2, Liberte and promus are trademarks of Boston Scientific Corporation or...rk of Abbott Laboratories group of companies. The promus Stent is a private-labeled XIENCE V Everolimus-Elu...

Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008

...business Increased U.S. drug-eluting stent (DES) leadership with Q4 market share of 47 percent; exited the quarter with 49 percent (25 percent promus and 24 percent TAXUS(R) stent systems) Grew Neuromodulation sales 10 percent over prior year "During the quarter, we contin...

Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels

...vices Agency. Abbott supplies a private-labeled XIENCE V to Boston Scientific called the PROMUS(TM) Everolimus-Eluting Coronary Stent System. promus is manufactured by Abbott and supplied to Boston Scientific as part of a distribution agreement between the two companies. Everolimus, develop...

Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter

...on Scientific's share of the market. Opening new promus accounts The Company announced it has: increased...ly to existing accounts, and has begun opening new promus accounts. The Company said it has ordered sufficient additional promus supply to continue opening new accounts through th...

Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System

...ach on a highly deliverable stent platform." The promus and XIENCE V stent systems are investigational devices in the U.S. and not yet approved for sale. promus is a private-labeled XIENCE V everolimus-eluting s... and distributed by Boston Scientific. TAXUS and promus are trademarks of Boston Scientific Corporation or...
Promus in Medical Technology

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

... approval for both the TAXUS Element Stent and the promus Element Stent Systems in the fourth quarter of thi...mated to be completed by the end of the year. The promus Element Stent System is currently being studied in...LATINUM clinical trial program, which compares the promus Element Stent System to the PROMUS(R) Stent System...

Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent

...ts with diabetes in December 2007. In the United States, the TAXUS Stents are not specifically indicated for use in patients with diabetes. The promus Stent is a private-labeled XIENCE V(R) Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific. XIENCE V...

Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms

...roups, and included 892 patients randomized to the promus (XIENCE V) Stent and 410 patients treated with the...esults and some subgroups at two years favored the promus (XIENCE V) Stent for rates of Major Adverse Cardia... Medical Officer of Boston Scientific. "While the promus (XIENCE V) Stent performed well against the TAXUS ...

Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

...y. Abbott also supplies a private-label version of XIENCE V to Boston Scientific called the PROMUS(R) Everolimus-Eluting Coronary Stent System. promus is designed and manufactured by Abbott and supplied to Boston Scientific as part of a distribution agreement between the two companies. Everolimu...

Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents

...g stents -- the TAXUS Element(TM) Paclitaxel-Eluting Coronary Stent and the promus Element Everolimus-Eluting Coronary Stent -- in Europe later this year. The TAXUS Liberte Atom, TAXUS Liberte Long, TAXUS Element and promus Element stents are investigational devices and are restricted under U.S. la...

Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent

...t 160 sites worldwide. The trial will compare the promus Element Everolimus-Eluting Coronary Stent to the P...strength, recoil and visibility. In addition, the promus Element Stent System incorporates the new Apex(TM)...alia. "The new alloy and stent design of the promus Element Stent promise to offer improved deliverabi...

Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent

...s Agency. Abbott also supplies a private-labeled XIENCE V to Boston Scientific called the PROMUS(TM) Everolimus-Eluting Coronary Stent System. promus is manufactured by Abbott and supplied to Boston Scientific as part of a distribution agreement between the two companies. Everolimus, develope...

SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents

...e are very pleased that both the TAXUS Express and promus Stents continue to perform so well in the SPIRIT I...growing body of positive clinical evidence for the promus Stent at two years," said Paul LaViolette, Chief O... drugs on two highly deliverable platforms." The promus Stent is a private-labeled XIENCE V Everolimus-Elu...

Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms

...tem ("TAXUS Stent") in 300 patients in Europe. The promus Stent is a private-labeled XIENCE V Everolimus-Elu...drugs on two deliverable platforms - the TAXUS and promus Stents. The results were presented today at the SC...ton Scientific's two DES platforms - the TAXUS and promus Stents - both performed extremely well in the SPIR...

Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures

... (TVR) at one year was also similar, with 6.1% for promus and 7.5% for TAXUS (p=0.41). The overall MACE (Ma...ston Scientific. "We look forward to launching the promus Stent in the U.S., which will complement our pacli...ring physicians a deliverable Olimus option." The promus Stent has CE Mark approval and is distributed in m...
Promus in Biological Technology

Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System

...clears the way for Boston Scientific to launch the promus Stent immediately in the U.S. The promus Stent expands Boston Scientific's drug-eluting ste... and everolimus) on separate DES platforms. "The promus Stent has shown outstanding deliverability, low la...

Boston Scientific Announces Schedule for ACC 2008

...ain CE Mark approval for both the XIENCE V and promus Stents. The promus Stent is a private-labeled XIENCE V Everolimus... clinical outcome data for Boston Scientific's promus Everolimus-Eluting Stent and compare them with...

Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents

...tent in patients in routine clinical practice. The promus Stent is a private-labeled XIENCE(TM) V Everolimus...y Abbott and distributed by Boston Scientific. The promus Stent is an investigational device in the United S...f the patients at each site, half will receive the promus Stent and half will receive either the Cypher or t...
Other Tags
(Date:2/27/2015)... Transfinder is very pleased to announce that ... to Work for in New York State for 2015. ... great work environment. People spend a lot of time ... There’s no reason why we can’t have fun while ... and CEO of Transfinder, a leading provider of intelligent ...
(Date:2/27/2015)... Cocaine is an extreme stimulant, causing the ... hostility. In a joint effort between Australian and American ... may soon rejoice in what has been a breakthrough ... response of cocaine, according to 7 News ... that the brain is continually communicating with the immune ...
(Date:2/27/2015)... Local lice removal service reports that cases ... areas of Pinecrest, Key Biscayne, Coral Gables, Miami Beach and ... attempt to isolate and eradicate the problem. , Among ... may be partly to blame. As kids put their heads ... contact that can allow for the spread of head lice. ...
(Date:2/27/2015)... Cucamonga, CA (PRWEB) February 27, 2015 ... STEM”U”LATE Your Mind: Pi Day event on March 14, ... about RDI-Engineering’s services, demonstrations on how to use engineering ... The event will be hosted by Moreno Valley College’s ... STEM Student Success Center (SSC) in hopes to encourage ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Prescription ... the U.S. Drug Enforcement Agency (DEA). Today, ... organizations continue to utilize the “Take-Back” guidelines for ... the FDA. , Eufaula Prescription Drug Disposal Event ... Industrial Drive in Eufaula, Oklahoma as the “Take-Back” ...
Breaking Medicine News(10 mins):Health News:Transfinder Named a Best Company to Work for in New York State 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 3Health News:Parents frustrated as selfies continue to contribute to the spread of head lice in Miami according to the largest Lice Removal Service in Miami called Lice Troopers 2Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3
(Date:2/5/2015)... DIEGO , Jan. 26, 2015   Epic Sciences ... of cancer, today announced that Murali Prahalad , Ph.D., ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which ... Mountain View, Calif. on January 26-28, 2015. ... "CTCs Come of Age as Biomarkers." Last year, Epic Sciences ...
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced ... Overview" report to their offering. , ... an individual is who she/he is claiming to be, and ... person,s unique physical characteristics, such as fingerprint, hand or palm ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
Other Contents